Sagoso, Aillie Celestine O.
HRN: 22-81-93 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/03/2023
AMPICILLIN 250MG (VIAL)
04/03/2023
04/10/2023
IVT
250mg
Q8
Bfc, R/o Uti
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes